Nicole Onetto - Net Worth and Insider Trading

Nicole Onetto Net Worth

The estimated net worth of Nicole Onetto is at least $0 dollars as of 2024-11-13. Nicole Onetto is the Director of Immunogen Inc and owns about 0 shares of Immunogen Inc (IMGN) stock worth over $0. Details can be seen in Nicole Onetto's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Nicole Onetto has not made any transactions after 2015-06-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Nicole Onetto

Nicole Onetto Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Nicole Onetto owns 5 companies in total, including Sunesis Pharmaceuticals Inc (SNSS) , Sierra Oncology Inc (SRRA) , and Immunogen Inc (IMGN) among others .

Click here to see the complete history of Nicole Onetto’s form 4 insider trades.

Insider Ownership Summary of Nicole Onetto

Ticker	Comapny	Transaction Date	Type of Owner
SNSS	Sunesis Pharmaceuticals Inc	2020-06-30	director
SRRA	Sierra Oncology Inc	2015-07-15	director
IMGN	Immunogen Inc	2015-06-15	director
		2019-09-30	director
		2021-12-14	director

Nicole Onetto Latest Holdings Summary

Nicole Onetto currently owns a total of 1 stock. Nicole Onetto owns 0 shares of Immunogen Inc (IMGN) as of June 15, 2015, with a value of $0.

Latest Holdings of Nicole Onetto

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
IMGN	Immunogen Inc	2015-06-15	0	31.23	0

Holding Weightings of Nicole Onetto

Nicole Onetto Form 4 Trading Tracker

According to the SEC Form 4 filings, Nicole Onetto has made a total of 0 transactions in Immunogen Inc (IMGN) over the past 5 years. The most-recent trade in Immunogen Inc is the sale of 3,211 shares on June 15, 2015, which brought Nicole Onetto around $44,505.

Insider Trading History of Nicole Onetto

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Nicole Onetto Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Nicole Onetto Ownership Network

Ownership Network List of Nicole Onetto

No Data

Ownership Network Relation of Nicole Onetto

Nicole Onetto Owned Company Details

What does Sunesis Pharmaceuticals Inc do?

Who are the key executives at Sunesis Pharmaceuticals Inc?

Nicole Onetto is the director of Sunesis Pharmaceuticals Inc. Other key executives at Sunesis Pharmaceuticals Inc include director & See Remarks Dayton Misfeldt , VP & Finance Tina Gullotta , and See Remarks William P. Quinn .

Sunesis Pharmaceuticals Inc (SNSS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sunesis Pharmaceuticals Inc (SNSS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sunesis Pharmaceuticals Inc (SNSS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sunesis Pharmaceuticals Inc (SNSS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sunesis Pharmaceuticals Inc Insider Transactions

No Available Data

What does Sierra Oncology Inc do?

Who are the key executives at Sierra Oncology Inc?

Nicole Onetto is the director of Sierra Oncology Inc. Other key executives at Sierra Oncology Inc include director & 10 percent owner Vivo Opportunity Fund Holdings, L.p. , Chief Reg & Tech Ops Officer William D. Turner , and General Counsel Mary Christina Thomson .

Sierra Oncology Inc (SRRA) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sierra Oncology Inc Insider Transactions

No Available Data

What does Immunogen Inc do?

Who are the key executives at Immunogen Inc?

Nicole Onetto is the director of Immunogen Inc. Other key executives at Immunogen Inc include director & Chief Executive Officer Mark J Enyedy , Chief Business Officer Stacy Ann Coen , and V.P.-Fin. & Prin. Acctg. Off. Renee Lentini .

Immunogen Inc (IMGN) Insider Trades Summary

Over the past 18 months, Nicole Onetto made no insider transaction in Immunogen Inc (IMGN). Other recent insider transactions involving Immunogen Inc (IMGN) include a net sale of 1,058,614 shares made by Theresa Wingrove , a net sale of 301,809 shares made by Stacy Ann Coen , and a net sale of 377,001 shares made by Renee Lentini .

In summary, during the past 3 months, insiders sold 0 shares of Immunogen Inc (IMGN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,785,085 shares of Immunogen Inc (IMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,785,085 shares.

Immunogen Inc (IMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Immunogen Inc Insider Transactions

No Available Data

What does Viracta Therapeutics Inc do?

Who are the key executives at Viracta Therapeutics Inc?

Nicole Onetto is the director of Viracta Therapeutics Inc. Other key executives at Viracta Therapeutics Inc include Chief Executive Officer Daniel R. Chevallard , director & President and CEO Mark Rothera , and Chief Medical Officer Darrel P. Cohen .

Viracta Therapeutics Inc (VIRX) Insider Trades Summary

Over the past 18 months, Nicole Onetto made no insider transaction in Viracta Therapeutics Inc (VIRX). Other recent insider transactions involving Viracta Therapeutics Inc (VIRX) include a net sale of 14,272 shares made by Daniel R. Chevallard , and a net purchase of 100,000 shares made by Mark Rothera .

In summary, during the past 3 months, insiders sold 0 shares of Viracta Therapeutics Inc (VIRX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 14,272 shares of Viracta Therapeutics Inc (VIRX) were sold and 100,000 shares were bought by its insiders, resulting in a net purchase of 85,728 shares.

Viracta Therapeutics Inc (VIRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

Viracta Therapeutics Inc Insider Transactions

No Available Data

What does Bolt Biotherapeutics Inc do?

Who are the key executives at Bolt Biotherapeutics Inc?

Nicole Onetto is the director of Bolt Biotherapeutics Inc. Other key executives at Bolt Biotherapeutics Inc include Chief Financial Officer William P. Quinn , 10 percent owner Vivo Capital Fund Viii, L.p. , and 10 percent owner Novo Holdings A/s .

Bolt Biotherapeutics Inc (BOLT) Insider Trades Summary

Over the past 18 months, Nicole Onetto made no insider transaction in Bolt Biotherapeutics Inc (BOLT). Other recent insider transactions involving Bolt Biotherapeutics Inc (BOLT) include a net sale of 200,000 shares made by Edgar Engleman , a net sale of 89,454 shares made by Vivo Capital Fund Viii, L.p. , and a net purchase of 11,829 shares made by William P. Quinn .

In summary, during the past 3 months, insiders sold 0 shares of Bolt Biotherapeutics Inc (BOLT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 289,454 shares of Bolt Biotherapeutics Inc (BOLT) were sold and 11,829 shares were bought by its insiders, resulting in a net sale of 277,625 shares.

Bolt Biotherapeutics Inc (BOLT)'s detailed insider trading history can be found in Insider Trading Tracker table.

Bolt Biotherapeutics Inc Insider Transactions

No Available Data

Nicole Onetto Mailing Address

Above is the net worth, insider trading, and ownership report for Nicole Onetto. You might contact Nicole Onetto via mailing address: 58 S Service Rd, Melville Ny 11747.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.